BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26885215)

  • 21. Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis.
    Feng YQ; Li YU; Xiao WD; Wang GX; Li YO
    Genet Mol Res; 2015 Oct; 14(4):13391-402. PubMed ID: 26535654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis.
    Shi XY; Shen Q
    Genet Mol Res; 2015 Jul; 14(3):8211-8. PubMed ID: 26345746
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    He L; Shen Y
    Onco Targets Ther; 2017; 10():227-238. PubMed ID: 28123304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk.
    Yuan C; Liu X; Li R; Yan S; Kong B
    Arch Med Sci; 2020; 16(3):682-691. PubMed ID: 32399118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Kamali M; Hamadani S; Neamatzadeh H; Mazaheri M; Zare Shehneh M; Modaress Gilani M; Haghighi F
    Asian Pac J Cancer Prev; 2017 Jul; 18(7):1743-1749. PubMed ID: 28749098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the interleukin-6 gene -572G/C polymorphism with cancer risk: a meta-analysis.
    Zhao Q; Zhang B; Chen Y; Li M; Zhao X; Fan H; Li SM
    Genet Mol Res; 2015 Dec; 14(4):16921-8. PubMed ID: 26681039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms of RAD51 and XRCC3 and acute myeloid leukemia risk: a meta-analysis.
    Li C; Liu Y; Hu Z; Zhou Y
    Leuk Lymphoma; 2014 Jun; 55(6):1309-19. PubMed ID: 23978154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of XPG gene rs751402 polymorphism with gastric cancer risk: a meta-analysis in the Chinese population.
    Liang J; Xu YY; Zhang C; Xia QR
    Int J Biol Markers; 2018 May; 33(2):174-179. PubMed ID: 29148016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population.
    Jara L; Acevedo ML; Blanco R; Castro VG; Bravo T; Gómez F; Waugh E; Peralta O; Cabrera E; Reyes JM; Ampuero S; González-Hormazábal P
    Cancer Genet Cytogenet; 2007 Oct; 178(1):65-9. PubMed ID: 17889711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis.
    Zhang K; Zhang L; Zhou J; Hao Z; Fan S; Yang C; Liang C
    Onco Targets Ther; 2016; 9():567-77. PubMed ID: 26869801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis.
    Xu T; Zhang S; Qiu D; Li X; Fan Y
    Gene; 2020 Oct; 759():144972. PubMed ID: 32739585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
    Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
    Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of IL-6 -174G/C polymorphism and psoriasis risk.
    Nie G; Xie CL; Cao YJ; Xu MM; Shi X; Zou AL; Qi JH
    Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis.
    Ding XP; Feng L; Ma L
    Asian Pac J Cancer Prev; 2012; 13(8):3937-42. PubMed ID: 23098496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.
    Tavakolpour S
    Mult Scler Relat Disord; 2016 Jul; 8():66-73. PubMed ID: 27456877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis.
    Irshad M; Mandal RK; Al-Drees A; Khalil MS; Abdulghani HM
    Asian Pac J Cancer Prev; 2015; 16(14):5663-7. PubMed ID: 26320432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of
    Wu Z; Xu XW; Zhang XW
    Ther Clin Risk Manag; 2017; 13():821-830. PubMed ID: 28721062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mEH Tyr113His polymorphism and the risk of ovarian cancer development.
    Zhong JH; Zhang ZM; Li LQ
    J Ovarian Res; 2013 Jun; 6(1):40. PubMed ID: 23742121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.